Mechanisms of altered regulation of food intake in chronic kidney disease

Journal of Renal Nutrition

Volumn 21, Issue 1, 2011, Pages 7-11

  Carrero, Juan J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIA; CHRONIC KIDNEY FAILURE; EATING; FOOD INTAKE; HUMAN; PATHOPHYSIOLOGY; REVIEW;

ANOREXIA; APPETITE REGULATION; EATING; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 78650681957     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.10.004     Document Type: Review

References (51)

1. Carrero J.J. Identification of patients with eating disorders: clinical and biochemical signs of appetite loss in dialysis patients. J Ren Nutr 2009, 19:10-15.
2. Carrero J.J., Aguilera A., Stenvinkel P., et al. Appetite disorders in uremia. J Ren Nutr 2008, 18:107-113.
3. Lopes A.A., Elder S.J., Ginsberg N., et al. Lack of appetite in haemodialysis patients-associations with patient characteristics, indicators of nutritional status and outcomes in the international DOPPS. Nephrol Dial Transplant 2007, 22:3538-3546.
4. Raff A.C., Lieu S., Melamed M.L., et al. Relationship of impaired olfactory function in ESRD to malnutrition and retained uremic molecules. Am J Kidney Dis 2008, 52:102-110.
5. Aguilera A., Bajo M.A., Espinoza M., et al. Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities. Am J Kidney Dis 2003, 42:787-796.
6. Wright M., Woodrow G., O'Brien S., et al. Disturbed appetite patterns and nutrient intake in peritoneal dialysis patients. Perit Dial Int 2003, 23:550-556.
7. Van Vlem B., Schoonjans R., Vanholder R., et al. Delayed gastric emptying in dyspeptic chronic hemodialysis patients. Am J Kidney Dis 2000, 36:962-968.
8. Wright M., Woodrow G., O'Brien S., et al. Cholecystokinin and leptin: their influence upon the eating behaviour and nutrient intake of dialysis patients. Nephrol Dial Transplant 2004, 19:133-140.
9. Perez-Fontan M., Cordido F., Rodriguez-Carmona A., et al. Short-term regulation of peptide YY secretion by a mixed meal or peritoneal glucose-based dialysate in patients with chronic renal failure. Nephrol Dial Transplant 2008, 23:3696-3703.
10. Perez-Fontan M., Cordido F., Rodriguez-Carmona A., et al. Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure. Kidney Int 2005, 68:2877-2885.
11. Rodriguez Ayala E., Pecoits-Filho R., Heimburger O., et al. Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 2004, 19:421-426.
12. Asakawa A., Inui A., Fujimiya M., et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005, 54:18-24.
13. Muscaritoli M., Molfino A., Chiappini M.G., et al. Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol 2007, 27:360-365.
14. Carrero J.J., Heimburger O., Lindholm B., et al. In reply to Mofino, et al. Am J Clin Nutr 2007, 86:1551-1553.
15. Ashby D.R., Ford H.E., Wynne K.J., et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int 2009, 76:199-206.
16. Carrero J.J., Stenvinkel P. Nutrition: can ghrelin improve appetite in uremic wasting?. Nat Rev Nephrol 2009, 5:672-673.
17. Mafra D., Guebre-Egziabher F., Cleaud C., et al. Obestatin and ghrelin interplay in hemodialysis patients. Nutrition 2010, 26:1100-1104.
18. Anderstam B., Mamoun A.H., Sodersten P., et al. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol 1996, 7:2453-2460.
19. Burrowes J.D., Larive B., Cockram D.B., et al. Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results from the HEMO study. J Ren Nutr 2003, 13:191-198.
20. Bossola M., Tazza L., Luciani G. Mechanisms and treatment of anorexia in end-stage renal disease patients on hemodialysis. J Ren Nutr 2009, 19:2-9.
21. Cheung W., Yu P.X., Little B.M., et al. Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 2005, 115:1659-1665.
22. Bossola M., Muscaritoli M., Valenza V., et al. Anorexia and serum leptin levels in hemodialysis patients. Nephron Clin Pract 2004, 97:c76-c82.
23. Carrero J.J., Qureshi A.R., Axelsson J., et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr 2007, 85:695-701.
24. Scholze A., Rattensperger D., Zidek W., et al. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity (Silver Spring) 2007, 15:1617-1622.
25. Carrero J.J., Cordeiro A.C., Lindholm B., et al. The emerging pleiotrophic role of adipokines in the uremic phenotype. Curr Opin Nephrol Hypertens 2010, 19:37-42.
26. Cordeiro A.C., Qureshi A.R., Stenvinkel P., et al. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant 2010, 25:562-568.
27. Yang H., Yang T., Baur J.A., et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 2007, 130:1095-1107.
28. Fulco M., Cen Y., Zhao P., et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 2008, 14:661-673.
29. Hallschmid M., Randeva H., Tan B.K., et al. Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans. Diabetes 2009, 58:637-640.
30. Yilmaz M.I., Saglam M., Carrero J.J., et al. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol Dial Transplant 2008, 23:959-965.
31. Carrero J.J., Witasp A., Stenvinkel P., et al. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels. Nephrol Dial Transplant 2010, 25:901-906.
32. Bossola M., Scribano D., Colacicco L., et al. Anorexia and plasma levels of free tryptophan, branched chain amino acids, and ghrelin in hemodialysis patients. J Ren Nutr 2009, 19:248-255.
33. Hiroshige K., Sonta T., Suda T., et al. Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant 2001, 16:1856-1862.
34. Zoccali C., Mallamaci F., Tripepi G., et al. Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease. J Am Soc Nephrol 2003, 14:2611-2617.
35. Lennie T.A. Sex differences in severity of inflammation-induced anorexia and weight loss. Biol Res Nurs 2004, 5:255-264.
36. Eckel L.A. Estradiol: a rhythmic, inhibitory, indirect control of meal size. Physiol Behav 2004, 82:35-41.
37. Gayle D.A., Desai M., Casillas E., et al. Gender-specific orexigenic and anorexigenic mechanisms in rats. Life Sci 2006, 79:1531-1536.
38. Rammohan M., Kalantar-Zadeh K., Liang A., et al. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr 2005, 15:345-355.
39. Kalantar-Zadeh K., Block G., McAllister C.J., et al. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004, 80:299-307.
40. Plata-Salaman C.R. Cytokines and feeding. Int J Obes Relat Metab Disord 2001, 25(Suppl 5):S48-S52.
41. Cheung W.W., Rosengren S., Boyle D.L., et al. Modulation of melanocortin signaling ameliorates uremic cachexia. Kidney Int 2008, 74:180-186.
42. Carrero J.J., Stenvinkel P. Inflammation in end-stage renal disease-what have we learned in 10 years?. Semin Dial 2010, 23:498-509.
43. Carrero J.J., Yilmaz M.I., Lindholm B., et al. Cytokine dysregulation in chronic kidney disease: how can we treat it?. Blood Purif 2008, 26:291-299.
44. Sonikian M., Metaxaki P., Papavasileiou D., et al. Effects of interleukin-6 on depression risk in dialysis patients. Am J Nephrol 2010, 31:303-308.
45. Chen L.P., Chiang C.K., Chan C.P., et al. Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients?. Am J Kidney Dis 2006, 47:815-822.
46. Chen K., Li F., Li J., et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 2006, 12:425-432.
47. Snaedal S., Heimburger O., Qureshi A.R., et al. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kidney Dis 2009, 53:1024-1033.
48. Cangiano C., Laviano A., Muscaritoli M., et al. Cancer anorexia: new pathogenic and therapeutic insights. Nutrition 1996, 12(Suppl 1):S48-S51.
49. Ando T., Dunn A.J. Mouse tumor necrosis factor-alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice. Neuroimmunomodulation 1999, 6:319-329.
50. Suliman M.E., Qureshi A.R., Stenvinkel P., et al. Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. Am J Clin Nutr 2005, 82:342-349.
51. Carrero J.J., Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 2009, 4(Suppl 1):S49-S55.